20 February 2025
Cirata plc
("Cirata" or the "Company")
Total Voting Rights
Notification under Rule 5.6.1 Financial Conduct Authority Disclosure and Transparency Rules:
The Company's issued share capital at 19 February 2025 consisted of 126,340,251 ordinary shares of ten pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury.
Therefore, the total number of voting rights in the Company is 126,340,251. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.
Of the total of 126,340,251 Ordinary Shares of ten pence each:
· 126,340,251 are admitted under ISIN JE00B6Y3DV84, ticker CRTA.
For further information, please contact:
| Cirata | Via FTI Consulting |
| Stephen Kelly, Chief Executive Officer | |
| Ricardo Moura, Chief Financial Officer | |
| Daniel Hayes, Investor Relations | |
| | |
|
FTI Consulting |
+44 (0)20 3727 1137 |
| Matt Dixon / Kwaku Aning / Usama Ali |
|
| |
|
|
Stifel (Nomad and Joint Broker) |
+44 (0)20 7710 7600 |
| Fred Walsh / Ben Good / Sarah Wong |
|
| |
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 3100 2000 |
| Max Jones / John More |
|
About Cirata
Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.